Company Luoxin Pharmaceuticals Group Stock Co., Ltd.

002793

CNE1000026S7

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
4.63 ^CNY	+2.89%		+7.18%	-13.62%

Apr. 26	Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 08	Luoxin Pharma Gets Right to Use Shenzhen Shishijijun Biotechnology's Fecal Microbiota Transplant Technology	MT

Luoxin Pharmaceuticals Group Stock Co Ltd, formerly Zhejiang Doyin Pump Industry Co Ltd, is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company operates two segments. The Pharmaceutical Industry segment is engaged in the research and development, manufacturing and sales of chemical drug preparations and raw and auxiliary drugs. Its main products are digestive drugs, respiratory drugs and antibiotic drugs, among others. The Pharmaceutical Business segment is engaged in the sales and logistics of agent drugs and medical devices. The Company conducts its businesses in the domestic market.

Number of employees: 4,582

Managers	Title	Age	Since
Zhen Teng Liu CEO	Chief Executive Officer	38	20-04-22
Xian Chen DFI	Director of Finance/CFO	41	21-07-07
Hong Yan Liu BRD	Director/Board Member	42	23-01-30
Meng Li BRD	Director/Board Member	47	21-04-26
Xue Yun Zhu IRC	Investor Relations Contact	-	-
Feng Sheng Han SEC	Corporate Secretary	49	20-04-22

Members of the board	Title	Age	Since
Feng Sheng Han SEC	Corporate Secretary	49	20-04-22
Liang Wei Song CHM	Chairman	44	23-01-30
Yun Pei Guo BRD	Director/Board Member	76	21-05-18
Zhi Ang Wu BRD	Director/Board Member	58	20-04-22
Zhen Fei Liu BRD	Director/Board Member	36	11-03-31
Zhen Teng Liu CEO	Chief Executive Officer	38	20-04-22
Xia Xu BRD	Director/Board Member	52	20-04-22
Meng Li BRD	Director/Board Member	47	21-04-26
Fang Xia BRD	Director/Board Member	35	23-01-30
Hong Yan Liu BRD	Director/Board Member	42	23-01-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,087,588,486	601,119,890 ( 55.27 %)	0	55.27 %

Name	Equities	%	Valuation
Xiu Bao Fang 18.56 %	110,736,346	18.56 %	70 M ¥
Deyi (Zhuhai) Capital Management Co. Ltd. 17.17 %	102,443,530	17.17 %	65 M ¥
Bin Zhang 5.874 %	35,050,459	5.874 %	22 M ¥
Lai Yang Chen 5.874 %	35,050,458	5.874 %	22 M ¥
Maui Jue Zhi La 5.765 %	34,400,000	5.765 %	22 M ¥
Dong Hui Fang 3.500 %	20,884,500	3.500 %	13 M ¥
Qianhai Fangzhou Asset Management Co. Ltd. 3.345 %	19,960,758	3.345 %	13 M ¥
SHANDONG LUOXIN HOLDINGS CO LTD 3.184 %	19,000,000	3.184 %	12 M ¥
Ally Bridge Group HK Ltd 3.047 %	18,185,013	3.047 %	12 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD. 2.809 %	16,759,622	2.809 %	11 M ¥

Name	Equities	%	Valuation
Bao Qi Liu 53.14 %	260,846,120	53.14 %	166 M ¥
Ally Bridge Group HK Ltd 11.16 %	54,759,382	11.16 %	35 M ¥
Shanghai Juezhi Investment Management Co. Ltd. 7.696 %	37,776,218	7.696 %	24 M ¥
Lai Yang Chen 3.766 %	18,484,216	3.766 %	12 M ¥
Bin Zhang 3.766 %	18,484,216	3.766 %	12 M ¥
Deyi (Zhuhai) Capital Management Co. Ltd. 2.168 %	10,640,378	2.168 %	7 M ¥
Qianhai Fangzhou Asset Management Co. Ltd. 2.145 %	10,526,509	2.145 %	7 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD. 1.797 %	8,822,537	1.797 %	6 M ¥
Hai Feng Hou 1.358 %	6,663,480	1.358 %	4 M ¥
Feng Xu 1.164 %	5,715,227	1.164 %	4 M ¥

Luoxin Pharmaceuticals Group Stock Co., Ltd.

Building 4 18, Luoqi Road

276017, Linyi

http://www.luoxin.cn

address Luoxin Pharmaceuticals Group Stock Co., Ltd.(002793)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.	-13.62%	696M
ELI LILLY AND COMPANY	+26.08%	662B
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
PFIZER, INC.	-3.40%	157B